```html

Otitis Bullosa – Comprehensive Medical Guide

Overview

Otitis bullosa (also called bullous myringitis) is an inflammation of the middle ear that is characterized by the formation of fluid‑filled blisters (bullae) on the tympanic membrane (eardrum). The condition usually develops as a complication of acute otitis media (AOM) but can also arise from viral infections, allergic reactions, or eustachian tube dysfunction.

• Age groups affected: Most common in children aged 5‑15 years, but it also occurs in adults, especially those with recurrent ear infections or chronic eustachian‑tube blockage.
• Gender: Slight male predominance (≈55 % of cases) has been reported, though differences are small.
• Prevalence: Bullous myringitis accounts for 5‑10 % of all acute otitis media episodes in pediatric populations (CDC, 2022). In the United States, an estimated 2‑3 % of children experience at least one episode before age 7.
• Geographic distribution: Rates are higher in regions with colder climates and where viral upper‑respiratory infections are common.

Symptoms

The hallmark of otitis bullosa is the presence of one or more translucent or yellow‑white vesicles on the eardrum. Symptoms can range from mild discomfort to severe pain.

• Ear pain (otalgia): Sudden, sharp pain that may worsen when lying down.
• Fullness or pressure sensation: Feeling that the ear is “plugged.”
• Hearing loss: Typically mild to moderate conductive loss that improves as the bullae resolve.
• Tinnitus: Ringing or buzzing in the affected ear.
• Otorrhea: Clear, mucoid, or occasionally purulent discharge if the bullae rupture.
• Fever: Low‑grade (≤38.5 °C/101 °F) in many children; higher fevers suggest a concurrent bacterial infection.
• Vertigo or balance disturbance: Rare, but may occur if the middle ear inflammation spreads to the inner ear.
• Facial nerve involvement: Extremely rare; presents as facial weakness and requires urgent evaluation.

Causes and Risk Factors

Otitis bullosa is not a disease by itself; it is a manifestation of an underlying middle‑ear process.

Primary Causes

1. Acute otitis media (AOM): The most frequent trigger. Bacterial pathogens such as Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis produce toxins that lead to blister formation.
2. Viral upper‑respiratory infections: Adenovirus, influenza, and respiratory syncytial virus (RSV) can cause inflammation and fluid accumulation.
3. Allergic reactions: Seasonal or environmental allergens can increase eustachian‑tube edema, predisposing to bullous changes.
4. Trauma or barotrauma: Rapid pressure changes (e.g., during air travel or diving) may rupture the eardrum, creating bullae-like lesions.

Risk Factors

• Age 5‑15 years (peak incidence)
• Day‑care attendance or exposure to other children with respiratory infections
• Second‑hand smoke exposure – increases middle‑ear inflammation (CDC, 2023)
• Allergic rhinitis or asthma
• Recent upper‑respiratory infection (within 7‑10 days)
• Anatomical eustachian‑tube dysfunction (e.g., cleft palate)
• Immunocompromise (e.g., HIV, chemotherapy)

Diagnosis

Diagnosis is primarily clinical, based on a detailed history and otoscopic examination.

History Taking

• Onset and character of ear pain
• Recent sore throat, cold, or sinus infection
• Exposure to smoke or allergens
• Vaccination history (particularly pneumococcal and influenza vaccines)

Physical Examination

1. Otoscopy: Visualization of one or more shiny, fluid‑filled vesicles on the tympanic membrane. The bullae are often surrounded by erythema and may coalesce.
2. Pneumatic otoscopy: Reduced mobility of the tympanic membrane indicates middle‑ear effusion.
3. Hearing assessment: Whisper test or handheld audiometer to gauge conductive loss.

Ancillary Tests

• Tympanometry: Confirms middle‑ear fluid and assesses eustachian‑tube function.
• Pure‑tone audiometry: Baseline hearing test, especially in older children and adults.
• Middle‑ear fluid culture: Reserved for severe or recurrent cases; a gentle aspiration under otomicroscopy can identify bacterial pathogens.
• Imaging (CT or MRI): Rarely needed, only if there is suspicion of mastoiditis, cholesteatoma, or intracranial spread.

Treatment Options

The therapeutic goal is to relieve pain, eradicate infection (if bacterial), and prevent complications.

Pharmacologic Management

1. Analgesics:
   • Acetaminophen (Paracetamol) 10‑15 mg/kg every 4‑6 h
   • Ibuprofen 5‑10 mg/kg every 6‑8 h (if no contraindications)
   These reduce pain and fever; they are first‑line for most patients.
2. Antibiotics: Indicated when bacterial AOM is suspected or if symptoms persist >48 h without improvement.
   • Amoxicillin 80‑90 mg/kg/day divided BID for 7‑10 days (first‑line)
   • High‑dose amoxicillin‑clavulanate for recent antibiotic exposure or resistant organisms.
   • Alternatives: cefdinir, cefuroxime, or azithromycin (single dose or 5‑day course).
   Source: American Academy of Pediatrics (AAP) Otitis Media Guidelines, 2022.
3. Corticosteroid ear drops: A short course of hydrocortisone 0.5 % drops can accelerate resolution of bullae, but evidence is limited. Use only under physician direction.
4. Decongestants & antihistamines: May help in patients with allergic components but are not routinely recommended for children.

Procedural Interventions

• Myringotomy: Small incision in the tympanic membrane to drain fluid and relieve pressure. Indicated for severe pain, persistent effusion >2 weeks, or when oral antibiotics fail.
• Tympanostomy tube placement: For recurrent otitis media with bullous changes, especially in children with >3 episodes in 6 months or >4 in a year.
• Aspiration of bullae: Under otomicroscopic guidance, a fine needle may be used to rupture large bullae that cause severe discomfort.

Lifestyle and Supportive Measures

1. Warm compresses over the affected ear for 10‑15 minutes, 3‑4 times daily.
2. Maintain adequate hydration to thin secretions.
3. Elevate the head of the bed (30‑45°) to improve eustachian‑tube drainage, especially at night.
4. Avoid water entry into the ear (use ear plugs while bathing) until the bullae resolve.

Living with Otitis Bullosa

While most episodes resolve within 1‑2 weeks, patients can take steps to minimize discomfort and reduce recurrence.

• Pain monitoring: Keep a diary of pain scores (0‑10). If pain rises above 6 or is unrelieved by scheduled analgesics, contact your provider.
• School/Work accommodations: Children may need a brief absence (1‑2 days). Adults should avoid noisy environments that aggravate the ear.
• Hygiene: Gently clean the outer ear with a washcloth; never insert cotton swabs or objects into the canal.
• Follow‑up: Re‑examination 48‑72 h after starting antibiotics to ensure bullae are shrinking. Additional follow‑up at 2‑3 weeks to confirm hearing returns to baseline.
• Hearing protection: If temporary conductive loss persists, avoid situations requiring precise hearing (e.g., operating heavy machinery).

Prevention

Because otitis bullosa is often a sequel to common respiratory infections, preventive strategies focus on reducing those antecedent illnesses and optimizing ear health.

1. Vaccination:
   • Pneumococcal conjugate vaccine (PCV13) – reduces bacterial AOM by ~20 %.
   • Annual influenza vaccine – lowers viral upper‑respiratory infections, a key trigger.
2. Breastfeeding: Exclusive breastfeeding for ≥6 months cuts AOM risk by ~30 % (WHO, 2022).
3. Limit tobacco smoke exposure: Smoke increases middle‑ear inflammation; establish a smoke‑free home.
4. Hand hygiene: Frequent hand washing in children reduces viral spread.
5. Allergy control: Use saline nasal rinses, antihistamines, or intranasal steroids as directed.
6. Proper bottle‑feeding position: Keep infant semi‑upright to prevent fluid from entering the eustachian tube.
7. Prompt treatment of colds and sinus infections: Early use of saline irrigations and, when indicated, appropriate antibiotics can reduce middle‑ear complications.

Complications

If left untreated or inadequately managed, otitis bullosa can lead to several serious outcomes.

• Mastoiditis: Infection spreads to the mastoid air cells; presents with post‑auricular swelling, fever, and tenderness.
• Chronic otitis media with effusion (COME): Persistent fluid for >3 months can cause long‑term conductive hearing loss.
• Perforated tympanic membrane: Rupture of the eardrum may heal spontaneously but can become chronic.
• Conductive hearing loss: Especially concerning in children due to impacts on speech and language development.
• Intracranial complications: Rare but include meningitis, brain abscess, or lateral sinus thrombosis; they require immediate hospitalization.

When to Seek Emergency Care

---

**References**

1. American Academy of Pediatrics. “Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Acute Otitis Media.” Pediatrics, 2022.
2. Centers for Disease Control and Prevention (CDC). “Otitis Media.” Updated 2022.
3. Mayo Clinic. “Bullous Myringitis.” Accessed May 2026.
4. World Health Organization. “Pneumococcal Conjugate Vaccine Position Paper.” 2023.
5. Cleveland Clinic. “Ear Infections (Otitis Media) in Children.” 2024.
6. National Institutes of Health (NIH). “Eustachian Tube Dysfunction.” 2023.

```